Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Prognostic potential of fusion gene analysis using plasma cell-free RNA in malignant bone and soft tissue tumours

1 Apr 2025

Abstract excerpt

BACKGROUND: Liquid biopsy, which facilitates minimally invasive analysis of body fluid samples, has considerable potential as a diagnostic and prognostic tool in various cancers. Analysis of circulating tumour cells, circulating tumour DNA, and exosomes in liquid biopsies has advantages and disadvantages. However, their utility in rare cancers, such as malignant bone and soft tissue tumours, remains unknown. In...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer Genomics and Diagnostics
Share to Extracellular vesicles in disease
Share to Sarcoma Diagnosis and Treatment

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 40170158
DOI: 10.1186/s12885-025-13950-2

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Prognostic potential of fusion gene analysis using plasma cell-free RNA in malignant bone and soft tissue tumoursPMID 40170158Read ↗

Molecular assessment of circulating exosomes toward liquid biopsy diagnosis of Ewing sarcoma family of tumorsSemantic proximity Read ↗

Identification of a blood-borne miRNA signature of synovial sarcomaSemantic proximity Read ↗

Detection of Novel Tyrosine Kinase Fusion Genes as Potential Therapeutic Targets in Bone and Soft Tissue Sarcomas Using DNA/RNA-based Clinical SequencingSemantic proximity Read ↗

Can a Liquid Biopsy Detect Circulating Tumor DNA With Low-passage Whole-genome Sequencing in Patients With a Sarcoma? A Pilot Evaluation.Semantic proximity Read ↗

Clinical application of RNA sequencing in sarcoma diagnosisSemantic proximity Read ↗

Unlocking the Potential of ctDNA in Sarcomas: A Review of Recent AdvancesSemantic proximity Read ↗

Detection of Structural Variants in Circulating Cell-Free DNA from Sarcoma Patients Using Next Generation SequencingSemantic proximity Read ↗

The Circulating Nucleic Acid Characteristics of Non-Metastatic Soft Tissue Sarcoma Patients.Semantic proximity Read ↗

Use of liquid biopsies to monitor disease progression in a sarcoma patient: a case report.Semantic proximity Read ↗

Recurrent and novel fusions detected by targeted RNA sequencing as part of the diagnostic workflow of soft tissue and bone tumoursSemantic proximity Read ↗

Development and validation of an RNA sequencing panel for gene fusions in soft tissue sarcomaSemantic proximity Read ↗

Clinical insights into circulating free-DNA in patients with bone sarcomas and ewing sarcoma.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.